Predictmedix AI Inc. (3QP0) - Net Assets

Latest as of : €- EUR

Based on the latest financial reports, Predictmedix AI Inc. (3QP0) has net assets worth €- EUR as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Predictmedix AI Inc. - Net Assets Trend (None–None)

This chart illustrates how Predictmedix AI Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Predictmedix AI Inc. (None–None)

The table below shows the annual net assets of Predictmedix AI Inc. from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to Predictmedix AI Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

Predictmedix AI Inc. Competitors by Market Cap

The table below lists competitors of Predictmedix AI Inc. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Predictmedix AI Inc.'s equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares Predictmedix AI Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently Predictmedix AI Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares Predictmedix AI Inc.'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $32,773,339,810
  • Average return on equity (ROE) among peers: -13.82%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Predictmedix AI Inc. (3QP0) €- N/A N/A $3.14 Million
Sysmex Corporation (0YX) $188.09 Billion 19.26% 0.42x $4.84 Billion
HeraMED Limited (1I4) $6.15 Million -86.78% 0.27x $26.40 Million
MAUNA KEA TECHNOL.EO -04 (1MK) $-10.33 Million 0.00% 0.00x $32.08 Million
INFUSYSTEMS HLDG.DL-0001 (1TZ) $57.33 Million 11.56% 0.75x $167.65 Million
PHC HOLDINGS CORP. (2GY) $139.16 Billion -9.26% 3.06x $740.08 Million
Q-linea AB (publ) (3F80) $430.45 Million -53.77% 0.13x $39.79 Million
Guerbet SA (4G8) $314.80 Million 9.19% 2.27x $133.92 Million
Peijia Medical Limited (4WO) $-558.21 Million 0.00% 0.00x $403.65 Million
ENVVENO MEDICAL DL-00001 (5HJ) $42.16 Million -51.75% 0.07x $196.50K
GENTIAN DIAGNOST. NO -01 (6FK) $194.05 Million 23.34% 0.18x $54.58 Million

About Predictmedix AI Inc.

F:3QP0 Germany Medical Devices
Market Cap
$3.14 Million
€2.69 Million EUR
Market Cap Rank
#33051 Global
#4729 in Germany
Share Price
€0.01
Change (1 day)
+0.00%
52-Week Range
€0.01 - €0.06
All Time High
€0.06
About

Predictmedix AI Inc. develops artificial intelligence powered technologies for general workplace health and safety, and health care industry. It operates in two segments, Workplace Health and Safety, and Healthcare. The company offers infectious disease symptom screening solutions to identify persons who test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID… Read more